News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
485,730 Results
Type
Article (7994)
Company Profile (141)
Press Release (477594)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166715)
Career Advice (303)
Deals (25738)
Drug Delivery (7)
Drug Development (52796)
Employer Resources (14)
FDA (9749)
Job Trends (8573)
News (238064)
Policy (17882)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (490)
Accelerated approval (26)
ADA (18)
Adcomms (1)
Allergies (98)
Alliances (33155)
ALS (108)
Alzheimer's disease (985)
Antibody-drug conjugate (ADC) (284)
Approvals (10409)
Artificial intelligence (333)
ASCO (159)
Autoimmune disease (220)
Automation (29)
Bankruptcy (263)
Belgium (1)
Best Places to Work (6961)
BIO (36)
Biologics (9)
BIOSECURE Act (1)
Biosimilars (114)
BioSpace Insights (17)
Biotechnology (89)
Bispecific (1)
Bladder cancer (139)
Brain cancer (31)
Breast cancer (519)
Cancer (3759)
Cardiovascular disease (226)
Career advice (245)
Career pathing (1)
CAR-T (178)
CDC (1)
CDMO (15)
Celiac Disease (1)
Cell therapy (486)
Cervical cancer (35)
Clinical research (48040)
Collaboration (1279)
Commercialization (3)
Compensation (1533)
Complete response letters (34)
COVID-19 (762)
CRISPR (64)
C-suite (802)
Cystic fibrosis (87)
Data (5847)
Denatured (4)
Depression (106)
Dermatology (67)
Diabetes (354)
Diagnostics (4218)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (158)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (166)
Earnings (73748)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88111)
Executive appointments (713)
FDA (12491)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (24)
Funding (945)
Gene editing (126)
Generative AI (11)
Gene therapy (333)
GLP-1 (294)
Government (948)
Grass and pollen (2)
Guidances (281)
Healthcare (9368)
Hematology (94)
HIV (55)
Huntington's disease (23)
IgA nephropathy (68)
Immunology and inflammation (106)
Immuno-oncology (61)
Indications (162)
Infectious disease (954)
Inflammatory bowel disease (128)
Inflation Reduction Act (4)
Influenza (85)
Intellectual property (261)
Interviews (41)
IPO (12388)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5196)
Licensing (18)
Liver cancer (45)
Longevity (19)
Lung cancer (542)
Lymphoma (257)
Machine learning (29)
Management (3)
Manufacturing (565)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8678)
Medtech (8837)
Mergers & acquisitions (14409)
Metabolic disorders (726)
mRNA (62)
Multiple sclerosis (107)
NASH (4)
Neurodegenerative disease (227)
Neuropsychiatric disorders (40)
Neuroscience (1869)
NextGen: Class of 2026 (3151)
Non-profit (843)
Obesity (231)
Opinion (10)
Ovarian cancer (161)
Pain (177)
Pancreatic cancer (206)
Parkinson's disease (206)
Partnered (12)
Patents (497)
Patient recruitment (530)
Patient selection (2)
Peanut (32)
People (41356)
Peptides (2)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15518)
Phase 2 (21453)
Phase 3 (14464)
Pipeline (7687)
Policy (18)
Postmarket research (1570)
Preclinical (6553)
Press Release (34)
Prostate cancer (193)
Psychedelics (7)
Radiopharmaceuticals (195)
Rare diseases (588)
Real estate (3022)
Recruiting (6)
Regenerative medicine (2)
Regulatory (14957)
Reports (23)
Research institute (584)
Resumes & cover letters (45)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (102)
Series A (163)
Series B (122)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (90)
Sponsored (5)
Startups (2020)
Stomach cancer (3)
Supply chain (51)
Vaccines (334)
Venture capital (17)
Weight loss (75)
Women's health (88)
Date
Today (12)
Last 7 days (284)
Last 30 days (1390)
Last 365 days (19012)
2026 (13618)
2025 (19251)
2024 (22973)
2023 (26529)
2022 (34587)
2021 (37150)
2020 (33472)
2019 (23264)
2018 (17471)
2017 (18744)
2016 (17898)
2015 (24263)
2014 (21679)
2013 (18127)
2012 (20221)
2011 (20440)
2010 (20332)
Location
Africa (229)
Alabama (77)
Alaska (2)
Arizona (310)
Arkansas (11)
Asia (17959)
Australia (2107)
California (12346)
Canada (3237)
China (544)
Colorado (496)
Connecticut (427)
Delaware (214)
Europe (24689)
Florida (1854)
Georgia (393)
Hawaii (3)
Idaho (46)
Illinois (726)
India (52)
Indiana (323)
Iowa (16)
Japan (423)
Kansas (103)
Kentucky (32)
Louisiana (27)
Maine (26)
Maryland (1231)
Massachusetts (8100)
Michigan (314)
Minnesota (572)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (122)
New Hampshire (60)
New Jersey (2691)
New Mexico (12)
New York (2896)
North Carolina (1316)
North Dakota (4)
Northern California (6209)
Ohio (293)
Oklahoma (14)
Oregon (16)
Pennsylvania (2295)
Puerto Rico (21)
Rhode Island (30)
South America (406)
South Carolina (78)
South Dakota (1)
Southern California (5138)
Tennessee (125)
Texas (2004)
United States (40017)
Utah (372)
Vermont (1)
Virginia (159)
Washington D.C. (38)
Washington State (955)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
485,730 Results for "medicomp inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioCapital
Medicomp Systems Awarded Patent for Intelligent Prompting of Protocols
Medicomp Systems, a physician-driven provider of diagnostically connected patient data solutions, announced today that the United States Patent and Trademark Office (USPTO) has awarded Medicomp US Patent 10,600,505 for the intelligent prompting of protocols.
September 14, 2022
·
5 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Press Releases
Allumiqs Solutions Inc. and Allumiqs Corporation
September 15, 2026
·
1 min read
BioCapital
Medicomp Systems Cancels Participation in HIMSS20
Medicomp Systems, the leading provider of clinician-driven, point-of-care solutions that fix EHRs, announced today that the company is canceling its participation in the 2020 HIMSS Global Health Conference & Exhibition, March 9–13, 2020 in Orlando to protect the health and safety of its staff from the growing spread of the novel coronavirus (COVID-19).
March 4, 2020
·
2 min read
BioCapital
Medicomp Systems Introduces Dedicated Care Planning and Documentation Solution for Nurses at 2020 ANIA Annual Conference
Medicomp Systems, the leading provider of clinician-driven, point-of-care solutions that fix EHRs, announced today a new version of Quippe Nursing, the industry’s first dedicated care planning and clinical documentation solution
August 20, 2020
·
4 min read
Press Releases
Carlsmed, Inc. Announces Chief Operating Officer Appointment
September 8, 2026
·
2 min read
BioCapital
Holy Name Health and Medicomp Systems to Premiere Internally Developed EHR System at HIMSS20
Medicomp Quippe Clinical Data Engine will drive clinical documentation workflow for Harmony EHR system; Solution to be unveiled at health IT’s largest conference
March 2, 2020
·
4 min read
Press Releases
Glucotrack, Inc. Announces Reverse Stock Split
August 27, 2026
·
6 min read
Press Releases
PostEra’s Fertility programs acquired by EMD Serono, Inc.
September 9, 2026
·
2 min read
Press Releases
Propanc Biopharma Positions PRP’s EMT-Reversal Mechanism as a Complementary Backbone to Emerging RAS Inhibitors from Revolution Medicines, Inc. and Erasca, Inc.
September 16, 2026
·
12 min read
1 of 48,573
Next
